BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23323461)

  • 21. Biology-driven phase II trials: what is the optimal model for molecular selection?
    Andre F; Delaloge S; Soria JC
    J Clin Oncol; 2011 Apr; 29(10):1236-8. PubMed ID: 21343554
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular markers for cancer prognosis and treatment: have we struck gold?
    Nowsheen S; Aziz K; Panayiotidis MI; Georgakilas AG
    Cancer Lett; 2012 Dec; 327(1-2):142-52. PubMed ID: 22120674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted therapies and predictive markers in epithelial malignancies of the gastrointestinal tract.
    McIntire M; Redston M
    Arch Pathol Lab Med; 2012 May; 136(5):496-503. PubMed ID: 22229849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Locally advanced breast cancer (methods of treatment)].
    Portnoĭ SM
    Vopr Onkol; 2011; 57(5):553-8. PubMed ID: 22238923
    [No Abstract]   [Full Text] [Related]  

  • 25. Genomic medicine and targeted therapy for solid tumors.
    Stevens EA; Rodriguez CP
    J Surg Oncol; 2015 Jan; 111(1):38-42. PubMed ID: 25042935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of genomics on personalized cancer medicine.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatocellular carcinoma: molecular pathogenesis and novel targets for therapy].
    Marquardt JU; Galle PR; Teufel A
    Dtsch Med Wochenschr; 2012 Apr; 137(16):855-60. PubMed ID: 22495921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs as promising biomarkers for diagnosing human cancer.
    Huang Y; Yang S; Zhang J; Tan L; Jiang F; Li N; Cheng J; Lu Y; Dai Y
    Cancer Invest; 2010 Jul; 28(6):670-1. PubMed ID: 20210518
    [No Abstract]   [Full Text] [Related]  

  • 29. Exploring new ways to broaden the reach of molecular tumor testing.
    Leach B
    Am J Manag Care; 2012 Dec; 18(5 Spec No.):SP203. PubMed ID: 23437477
    [No Abstract]   [Full Text] [Related]  

  • 30. Biomarkers in cancer research and treatment: promises and challenges.
    Hainaut P; Plymoth A
    Curr Opin Oncol; 2011 Jan; 23(1):61. PubMed ID: 21321519
    [No Abstract]   [Full Text] [Related]  

  • 31. Genomic sequencing for cancer diagnosis and therapy.
    Wang L; Wheeler DA
    Annu Rev Med; 2014; 65():33-48. PubMed ID: 24274147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalized lung cancer treatment based on molecular determinants.
    Simon GR
    J S C Med Assoc; 2011 Oct; 107(5):183-4. PubMed ID: 22057801
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular tumor profiling for prediction of response to anticancer therapies.
    Walther Z; Sklar J
    Cancer J; 2011; 17(2):71-9. PubMed ID: 21427550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials.
    Zwierzina H; Bardelli A; Ciardiello F; Gariboldi M; Håkansson L; Lambrechts D; Lind GE; Loeffler-Ragg J; Schmoll H; Siena S; Tabernero J; Van Cutsem E
    Curr Opin Mol Ther; 2010 Dec; 12(6):703-11. PubMed ID: 21154162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cancer biomarker problem.
    Sawyers CL
    Nature; 2008 Apr; 452(7187):548-52. PubMed ID: 18385728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput sequencing set to enter patient care.
    Hede K
    J Natl Cancer Inst; 2012 Nov; 104(21):1620-1. PubMed ID: 23104214
    [No Abstract]   [Full Text] [Related]  

  • 37. [Molecular genetic tests in advanced non-small cell lung cancer: practical relevance].
    Sebastian M; Niederle N; Thomas M; Reck M; Schmittel A; Fischer B; Overbeck T; Gröschel A; Deppermann M; Pirker R; Huber RM; Eberhardt W; Griesinger F
    Dtsch Med Wochenschr; 2014 Oct; 139(41):2096-100. PubMed ID: 25268213
    [No Abstract]   [Full Text] [Related]  

  • 38. Critical comments for roles of biomarkers in the diagnosis and treatment of cancer.
    Saijo N
    Cancer Treat Rev; 2012 Feb; 38(1):63-7. PubMed ID: 21652149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetic tests for molecular markers of cancer].
    Miyachi H; Asai S
    Rinsho Byori; 2003 Dec; 51(12):1195-202. PubMed ID: 14743743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular medicine and the development of cancer chemopreventive agents.
    Izzotti A
    Ann N Y Acad Sci; 2012 Jul; 1259():26-32. PubMed ID: 22758633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.